Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7

Abstract excerpt

To the editor: In this journal and others, Ruter[1][1] and Raj[2][2] have previously reported superior response to treatment with DNA-hypomethylating agents, such as decitabine or azacitidine (AC), in adults with myelodysplastic syndrome (MDS) and clonal monosomy 7. The use of AC has not yet been

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Histone Deacetylase Inhibitors Research
• Share to Pneumocystis jirovecii pneumonia detection and treatment